Registry for Accelerated Partial Breast Irradiation With (SBRT) or (IMRT)

Accelerated Partial Breast Irradiation (PBI) With Stereotactic Body Radiation Therapy (SBRT) or Intensity Modulated Radiation Therapy (IMRT)

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04917640

Enrollment

Registered

2021-06-08

Start date

2021-06-30

Completion date

2024-12-31

Last updated

2021-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

This is a registry study that will be used to evaluate external beam radiation therapy methods for the accelerated treatment of breast cancer. Patients are being asked to take part in this registry because they have breast cancer and desire treatment with accelerated partial breast irradiation to be delivered by external beam methods.

Interventions

RADIATIONRadiation Therapy

Either SBRT or IMRT radiation therapy

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

50 Years to 100 Years

Inclusion criteria

* Greater than or equal to 50 years old Low to intermediate DCIS Tumor size \< or = to 2cm

Exclusion criteria

* BRCA positive Lobular histology Angiolymphatic invasion

Design outcomes

Primary

Measure	Time frame	Description
Number of participants with treatment and toxicity-related adverse events as assessed by CTCAE v4.0.	Through study completion, an average of 12 months	Toxicity will be assessed using the CTCAEv4.0 and recorded.

Secondary

Measure	Time frame	Description
Number of participants with ipsilateral breast recurrence	Through study completion, an average of 12 months	Number of participants with pathologically confirmed ipsilateral breast recurrence.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026